Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients

MELBOURNE, Australia, Oct. 30, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases including ...
Labiotech.eu

Novavax’s new strategy: Betting its future on partnerships

In an interview with Labiotech, Jacobs discussed the decisions behind Novavax’s transformation, the economics of its new ...

Matrix gains ground in Europe’s public sector — but replacing Teams is another matter

Projects at the European Commission and Swedish government agencies highlight the appeal of open, interoperable messaging ...
Business Insider

Auddia Announces Completion of LT350 Phase 1 Feasibility Study and Advancement to Phase 2/3 Engineering with Fresh Consulting

Phase 1 Validates LT350’s Canopy and Modular Cartridge Architecture Across All Engineering Domains Engagement Expands to Full Design/Engineering and Pilot Ready Deployment Timeline Supports Breaking ...

Going to see a rival store but deciding on nothing: Examples of competitive analysis items and 4 questions to narrow down your strategy

A similar store opened nearby.When I look it up online, there are many similar services lined up, and I feel like customers ...
futuremarketinsights

Ski Flywheel Market

How Big is the Ski Flywheel Market in 2026? The ski flywheel market is valued at USD 9.5 million in 2026 and is projected to reach USD 49.5 million by 2036, growing at a 17.9% CAGR as per FMI ...